EyePoint Pharmaceuticals, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2020
January 11, 2021 at 09:01 pm
EyePoint Pharmaceuticals, Inc. provided revenue guidance for the fourth quarter and full year 2020. For the quarter, the company net product revenues are estimated to be $6.2 million to $6.6 million versus $7.9 million in 2019.
For the year, the company net product revenues are estimated to be $20.3 million to $20.7 million for the full year 2020 as compared to $16.8 million for the full year 2019.